Your browser doesn't support javascript.
loading
Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations.
Xochelli, Aliki; Bikos, Vasilis; Polychronidou, Eleftheria; Galigalidou, Chrysi; Agathangelidis, Andreas; Charlotte, Frédéric; Moschonas, Panagiotis; Davis, Zadie; Colombo, Monica; Roumelioti, Maria; Sutton, Lesley-Ann; Groenen, Patricia; van den Brand, Michiel; Boudjoghra, Myriam; Algara, Patricia; Traverse-Glehen, Alexandra; Ferrer, Ana; Stalika, Evangelia; Karypidou, Maria; Kanellis, George; Kalpadakis, Christina; Mollejo, Manuella; Pangalis, Gerasimos; Vlamos, Panayiotis; Amini, Rose-Marie; Pospisilova, Sarka; Gonzalez, David; Ponzoni, Maurilio; Anagnostopoulos, Achilles; Giudicelli, Véronique; Lefranc, Marie-Paule; Espinet, Blanca; Panagiotidis, Panagiotis; Piris, Miguel Angel; Du, Ming-Qing; Rosenquist, Richard; Papadaki, Theodora; Belessi, Chrysoula; Ferrarini, Manlio; Oscier, David; Tzovaras, Dimitrios; Ghia, Paolo; Davi, Frederic; Hadzidimitriou, Anastasia; Stamatopoulos, Kostas.
Afiliação
  • Xochelli A; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
  • Bikos V; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Polychronidou E; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Galigalidou C; Information Technologies Institute, CERTH, Thessaloniki, Greece.
  • Agathangelidis A; Department of Informatics, Ionian University, Corfu, Greece.
  • Charlotte F; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
  • Moschonas P; Division of Experimental Oncology and Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute and Università Vita-Salute San Raffaele, Milan, Italy.
  • Davis Z; Department of Pathology, Hopital Pitie-Salpetriere and Sorbonne University, Paris, France.
  • Colombo M; Information Technologies Institute, CERTH, Thessaloniki, Greece.
  • Roumelioti M; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Sutton LA; Molecular Pathology, Ospedale Policlinico SanMartino, Genoa, Italy.
  • Groenen P; First Department of Propaedeutic Medicine, University of Athens, Athens, Greece.
  • van den Brand M; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Boudjoghra M; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Algara P; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Traverse-Glehen A; Department of Hematology, Hopital Pitie-Salpetriere and Sorbonne University, Paris, France.
  • Ferrer A; Hospital Virgen de la Salud, Toledo, Spain.
  • Stalika E; Department of Pathology and Hematology, Hospices Civils de Lyon Universite Lyon 1, Lyon, France.
  • Karypidou M; Laboratori de Citologia Hematològica i Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.
  • Kanellis G; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
  • Kalpadakis C; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Mollejo M; Hematopathology Department, Evangelismos Hospital, Athens, Greece.
  • Pangalis G; Department of Haematology, University of Crete, Heraklion, Greece.
  • Vlamos P; Hospital Virgen de la Salud, Toledo, Spain.
  • Amini RM; Department of Haematology, Athens Medical Center, Athens, Greece.
  • Pospisilova S; Department of Informatics, Ionian University, Corfu, Greece.
  • Gonzalez D; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Ponzoni M; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Anagnostopoulos A; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Giudicelli V; Pathology Unit, San Raffaele Scientific Institute, Milan, Italy.
  • Lefranc MP; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Espinet B; IMGT®, the international ImMunoGeneTics Information System®, Université de Montpellier, LIGM, Institut de Génétique Humaine IGH, UMR CNRS UM, Montpellier, France.
  • Panagiotidis P; IMGT®, the international ImMunoGeneTics Information System®, Université de Montpellier, LIGM, Institut de Génétique Humaine IGH, UMR CNRS UM, Montpellier, France.
  • Piris MA; Laboratori de Citologia Hematològica i Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.
  • Du MQ; First Department of Propaedeutic Medicine, University of Athens, Athens, Greece.
  • Rosenquist R; Pathology Department, IIS 'Fundacion Jimenez Diaz', Madrid, Spain.
  • Papadaki T; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.
  • Belessi C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Ferrarini M; Hematopathology Department, Evangelismos Hospital, Athens, Greece.
  • Oscier D; Hematology Department, Nikea General Hospital, Piraeus, Greece.
  • Tzovaras D; Direzione Scientifica, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliera Universitaria (AOU) San Martino-IST, Genoa, Italy.
  • Ghia P; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Davi F; Information Technologies Institute, CERTH, Thessaloniki, Greece.
  • Hadzidimitriou A; Division of Experimental Oncology and Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute and Università Vita-Salute San Raffaele, Milan, Italy.
  • Stamatopoulos K; Department of Hematology, Hopital Pitie-Salpetriere and Sorbonne University, Paris, France.
J Pathol ; 247(4): 416-421, 2019 04.
Article em En | MEDLINE | ID: mdl-30484876
ABSTRACT
The B cell receptor immunoglobulin (Ig) gene repertoires of marginal zone (MZ) lymphoproliferations were analyzed in order to obtain insight into their ontogenetic relationships. Our cohort included cases with MZ lymphomas (n = 488), i.e. splenic (SMZL), nodal (NMZL) and extranodal (ENMZL), as well as provisional entities (n = 76), according to the WHO classification. The most striking Ig gene repertoire skewing was observed in SMZL. However, restrictions were also identified in all other MZ lymphomas studied, particularly ENMZL, with significantly different Ig gene distributions depending on the primary site of involvement. Cross-entity comparisons of the MZ Ig sequence dataset with a large dataset of Ig sequences (MZ-related or not; n = 65 837) revealed four major clusters of cases sharing homologous ('public') heavy variable complementarity-determining region 3. These clusters included rearrangements from SMZL, ENMZL (gastric, salivary gland, ocular adnexa), chronic lymphocytic leukemia, but also rheumatoid factors and non-malignant splenic MZ cells. In conclusion, different MZ lymphomas display biased immunogenetic signatures indicating distinct antigen exposure histories. The existence of rare public stereotypes raises the intriguing possibility that common, pathogen-triggered, immune-mediated mechanisms may result in diverse B lymphoproliferations due to targeting versatile progenitor B cells and/or operating in particular microenvironments. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Genes de Imunoglobulinas / Linfoma de Zona Marginal Tipo Células B Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Pathol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Grécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Genes de Imunoglobulinas / Linfoma de Zona Marginal Tipo Células B Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Pathol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Grécia
...